Hiroshi Harada
Group of Radiation and Tumor Biology
Career-Path Promotion Unit for Young Life Scientists
Kyoto University
Yoshida Konoe-cho
Japan
Name/email consistency: high
- Microenvironments and cellular characteristics in the micro tumor cords of malignant solid tumors. Yeom, C.J., Goto, Y., Zhu, Y., Hiraoka, M., Harada, H. Int. J. Mol. Sci (2012)
- Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy. Harada, H., Itasaka, S., Zhu, Y., Zeng, L., Xie, X., Morinibu, A., Shinomiya, K., Hiraoka, M. Br. J. Cancer (2009)
- The Akt/mTOR pathway assures the synthesis of HIF-1alpha protein in a glucose- and reoxygenation-dependent manner in irradiated tumors. Harada, H., Itasaka, S., Kizaka-Kondoh, S., Shibuya, K., Morinibu, A., Shinomiya, K., Hiraoka, M. J. Biol. Chem. (2009)
- Diameter of tumor blood vessels is a good parameter to estimate HIF-1-active regions in solid tumors. Harada, H., Xie, X., Itasaka, S., Zeng, L., Zhu, Y., Morinibu, A., Shinomiya, K., Hiraoka, M. Biochem. Biophys. Res. Commun. (2008)
- The combination of hypoxia-response enhancers and an oxygen-dependent proteolytic motif enables real-time imaging of absolute HIF-1 activity in tumor xenografts. Harada, H., Kizaka-Kondoh, S., Itasaka, S., Shibuya, K., Morinibu, A., Shinomiya, K., Hiraoka, M. Biochem. Biophys. Res. Commun. (2007)
- Antitumor protein therapy; application of the protein transduction domain to the development of a protein drug for cancer treatment. Harada, H., Kizaka-Kondoh, S., Hiraoka, M. Breast. Cancer (2006)